MELFIAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Melfiat, and what generic alternatives are available?
Melfiat is a drug marketed by Numark and is included in two NDAs.
The generic ingredient in MELFIAT is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Melfiat
A generic version of MELFIAT was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MELFIAT?
- What are the global sales for MELFIAT?
- What is Average Wholesale Price for MELFIAT?
Summary for MELFIAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 1,902 |
| DailyMed Link: | MELFIAT at DailyMed |
US Patents and Regulatory Information for MELFIAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Numark | MELFIAT | phendimetrazine tartrate | TABLET;ORAL | 083790-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Numark | MELFIAT-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087487-001 | Oct 13, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
